Phase I Combination Ixabepilone + Cisplatin

NCT00832117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Ixabepilone
DRUG: Cisplatin
DRUG: Ixabepilone
DRUG: Cisplatin

Sponsor

R-Pharm